Hyrimoz

Hyrimoz, a biosimilar to Humira, had recently earned approval for the American market, promising enhanced accessibility in patient care. We were tasked to develop a series of educational videos tailored specifically for doctors and prescribers, equipping them with a thorough understanding of Hyrimoz, and empowering them to make informed decisions in their prescribing practices.

Recognizing the importance of engagement in conveying medical information, we took a unique approach. Alongside detailed narratives about the drug’s background and history, we incorporated particle-based animations. These animations were designed not only to illustrate complex concepts but also to maintain viewer interest throughout.

Through the formation of these particles, we guided viewers through the intricacies of Hyrimoz, ensuring comprehension without overwhelming complexity. These animations, while visually appealing, were purposeful additions aimed at enhancing the educational experience.

Our goal was to ensure that every moment spent learning about Hyrimoz was both informative and engaging. These videos signified a commitment to bridging the gap between innovation and accessibility in healthcare, one illuminated concept at a time.